In this episode, we discuss the management of multiple myeloma in LMICs with Dr. Andrés Gómez-De León from UANL, Monterrey, Mexico, and Dr. Aditya Jandial from PGIMER, Chandigarh, India. This episode was inspired by an article in Lancet Haematology titled “The Underrepresented Majority”, which highlighted the lack of access to some of the basic anti-myeloma drugs in LMICs and the resulting disparity in global outcomes.
Here are some of the sections discussed in this episode:
03:33 Diagnostic workup of myeloma in LMICs
15:46 Induction therapy for new diagnosed transplant-eligible myeloma
27:17 Early Transplant vs Delayed Transplant in the Context of LMICs
33:11 Maintenance therapy
37:27 Management of relapsed myeloma
45:30 Clinical Trials in LMICs. Is industry exploiting patients in LMICs?
Article by Dr. Gómez-De León in Lancet Haematology: https://pubmed.ncbi.nlm.nih.gov/36174637/
What is Blood Cancer Talks?
This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk